EXECUTIVE RETENTION AND SEPARATION AGREEMENTExecutive Retention and Separation Agreement • December 1st, 2015 • Emergent BioSolutions Inc. • Pharmaceutical preparations • Maryland
This Executive Retention and Separation Agreement (the "Agreement") is entered into as of November 24, 2015 by and between Emergent BioSolutions Inc., (the "Company"), and Barry Labinger (the "Executive" and together with the Company, the "Parties").
EXHIBIT 10.08 May 30, 2001 Mr. Mark O'Leary Dear Mark: This letter confirms the specific details of your transition and separation from Excite@Home, and is consistent with the terms of the Executive Retention and Separation Agreement letter dated May...Executive Retention and Separation Agreement • August 14th, 2001 • At Home Corp • Services-computer programming, data processing, etc.
EXECUTIVE RETENTION AND SEPARATION AGREEMENTExecutive Retention and Separation Agreement • May 7th, 2020 • Moderna, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Executive Retention Agreement (this “Agreement”) is entered into effective as of May 5, 2020 (the “Effective Date”) between Lorence Kim, M.D. (the “Executive”) and Moderna, Inc. (the “Company,” together with Executive, the “Parties”).
